Coherus BioSciences Inc (CHRS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: RETAIL-WOMEN'S CLOTHING STORES

450 WINKS LANE BENSALEM, PA 19020

Coherus Biosciences Inc is a biopharmaceutical company. The Company develops biosimilar therapeutics to aid patients.

Data as of 2021-02-27 10:59:50 -0500
Market Cap1.182 Billion Shares Outstanding72.794 Million Avg 30-day Volume1.396 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.03282 52-week High/Low22.22 / 10.86 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from CHRS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 189 197 -4.06% 51 (3.08%) 58 (3.61%) -12.07%
13F shares: 85.853 Million 85.759 Million 0.11% 27.265 Million 27.213 Million 0.19%
% Ownership 37.8428 37.7707 0.19%
New Positions: 23 34 -32.35% 4 7 -42.86%
Increased Positions 66 81 -18.52% 12 20 -40.0%
Closed Positions 27 21 28.57% 9 10 -10.0%
Reduced Positions 69 58 18.97% 25 21 19.05%
Total Calls 77.707 Thousand 38.769 Thousand 100.44% 0 11.5 Thousand -100.0%
Total Puts 53.228 Thousand 132.498 Thousand -59.83% 15.1 Thousand 11.3 Thousand 33.63%
PUT/CALL Ratio 0.68 3.42 -80.12% 0.98 -30.61%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CHRS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CHRS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

58.5 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

52.4 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ANICETTI VINCENT R CHIEF OPERATING OFFICER

  • Officer
59,739 2021-02-17 15

LANFEAR DENNIS M PRESIDENT & CEO

  • Officer
  • Director
0 2021-02-01 3

VIRET JEAN-FREDERIC CHIEF FINANCIAL OFFICER

  • Officer
61,295 2021-02-01 7

VEXLER VLADIMIR CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-01 4

HEALY JAMES

  • Director
0 2021-01-11 3

SZELA MARY T

  • Director
0 2021-01-11 2

LAWLIS V BRYAN

  • Director
0 2021-01-11 1

WAHLSTROM MATS

  • Director
0 2021-01-11 3

NUSSBAUM SAMUEL R MD

  • Director
0 2021-01-11 1

TZOUMAKAS KIMBERLY JO

  • Director
0 2021-01-11 3

MENDELSON ALAN C

  • Director
0 2021-01-05 2

STOLPER MARK

  • Director
0 2021-01-05 2

SATVAT ALI J.

  • Director
0 2020-01-10 0

RICHARDS CHRISTOS

  • Director
0 2020-01-10 0

V-SCIENCES INVESTMENTS PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
7,381,116 2019-12-30 0

HORTON DARLENE P SEE REMARKS

  • Officer
0 2019-01-18 0

FINCK BARBARA K CHIEF MEDICAL OFFICER

  • Officer
37,043 2018-09-10 0

WATLER PETER K. CHIEF TECHNICAL OFFICER

  • Officer
5,900 2018-02-01 0

TROENDLE AUGUST J.

  • Director
1,940,914 2018-02-01 0

HERMAN ALAN C. CHIEF SCIENTIFIC OFFICER

  • Officer
350,624 2017-12-15 0

FMR LLC

  • SEE REMARK 1
No longer subject to file 2016-08-08 0

LILLY ELI & CO

LILLY VENTURES FUND I LLC

  • FORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2014-11-12 0

KKR BIOSIMILAR L.P.

KKR BIOSIMILAR GP LLC

KKR FUND HOLDINGS L.P.

KKR FUND HOLDINGS GP LTD

KKR GROUP HOLDINGS L.P.

KKR GROUP LTD

KKR & CO. L.P.

KKR MANAGEMENT LLC

KRAVIS HENRY R

ROBERTS GEORGE R

  • 10% Owner
No longer subject to file 2014-11-12 0

DAIICHI SANKYO COMPANY, LTD

  • FORMER 10% OWNER
No longer subject to file 2014-11-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-02-19 16:11:59 -0500 2021-02-17 M 2,488 d 0 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-02-19 16:11:59 -0500 2021-02-17 S 2,488 $17.45 d 59,739 direct yes

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-02-19 16:11:59 -0500 2021-02-17 M 2,488 $2.50 a 62,227 direct

LANFEAR DENNIS M - Director - Officer PRESIDENT & CEO

2021-02-03 17:38:20 -0500 2021-02-01 A 125,000 a 125,000 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:37:27 -0500 2021-02-01 S 7,402 $21.55 d 61,295 direct yes

VEXLER VLADIMIR - Officer CHIEF SCIENTIFIC OFFICER

2021-02-03 17:39:18 -0500 2021-02-01 A 50,000 a 50,000 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:37:27 -0500 2021-02-01 M 7,402 $10.05 a 68,697 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-02-03 17:37:27 -0500 2021-02-01 M 7,402 d 54,167 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-27 16:15:38 -0500 2021-01-25 S 6,144 $19.00 d 61,295 direct yes

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-27 16:15:38 -0500 2021-01-25 S 40,000 $20.10 d 67,439 direct yes

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-27 16:15:38 -0500 2021-01-25 M 40,000 d 61,569 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-27 16:15:38 -0500 2021-01-25 M 40,000 $10.05 a 107,439 direct

LANFEAR DENNIS M - Director - Officer PRESIDENT & CEO

2021-01-26 16:37:41 -0500 2021-01-23 A 500,000 a 500,000 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-21 16:22:02 -0500 2021-01-19 M 2,500 $2.50 a 62,239 direct 6.6558 2.5641 16.6939 4 0.0 1

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-21 16:22:02 -0500 2021-01-19 M 2,500 d 2,488 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-21 16:22:02 -0500 2021-01-19 S 2,500 $17.94 d 59,739 direct yes 6.6558 2.5641 16.6939 4 0.0 1

SZELA MARY T - Director

2021-01-13 16:29:06 -0500 2021-01-11 A 20,000 a 20,000 direct

NUSSBAUM SAMUEL R MD - Director

2021-01-13 16:26:12 -0500 2021-01-11 A 20,000 a 20,000 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-13 16:22:21 -0500 2021-01-11 A 62,500 a 62,500 direct

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-13 16:23:21 -0500 2021-01-11 A 31,250 a 67,439 direct -1.4452 1.8899 1.8899 6 -1.4452 2

WAHLSTROM MATS - Director

2021-01-13 16:31:10 -0500 2021-01-11 A 20,000 a 20,000 direct

TZOUMAKAS KIMBERLY JO - Director

2021-01-13 16:27:46 -0500 2021-01-11 A 20,000 a 20,000 direct

VEXLER VLADIMIR - Officer CHIEF SCIENTIFIC OFFICER

2021-01-13 16:24:18 -0500 2021-01-11 A 62,500 a 62,500 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-13 16:22:21 -0500 2021-01-11 A 31,250 a 59,739 direct -1.4452 1.8899 1.8899 6 -1.4452 2

HEALY JAMES - Director

2021-01-13 16:30:28 -0500 2021-01-11 A 20,000 a 20,000 direct

LAWLIS V BRYAN - Director

2021-01-13 16:25:17 -0500 2021-01-11 A 20,000 a 20,000 direct

VEXLER VLADIMIR - Officer CHIEF SCIENTIFIC OFFICER

2021-01-13 16:24:18 -0500 2021-01-11 A 31,250 a 65,146 direct -1.4452 1.8899 1.8899 6 -1.4452 2

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-13 16:23:21 -0500 2021-01-11 A 62,500 a 62,500 direct

ANICETTI VINCENT R - Officer CHIEF OPERATING OFFICER

2021-01-12 16:53:32 -0500 2021-01-10 F 4,080 $18.18 d 28,489 direct 4.3503 4.3503 -5.8005 24.0719 10 -11.5429 30

VEXLER VLADIMIR - Officer CHIEF SCIENTIFIC OFFICER

2021-01-12 16:55:57 -0500 2021-01-10 F 4,080 $18.18 d 33,896 direct 4.3503 4.3503 -5.8005 24.0719 10 -11.5429 30

VIRET JEAN-FREDERIC - Officer CHIEF FINANCIAL OFFICER

2021-01-12 16:55:02 -0500 2021-01-10 F 4,080 $18.18 d 36,189 direct 4.3503 4.3503 -5.8005 24.0719 10 -11.5429 30

STOLPER MARK - Director

2021-01-07 16:32:38 -0500 2021-01-05 A 40,000 a 40,000 direct

MENDELSON ALAN C - Director

2021-01-07 16:31:51 -0500 2021-01-05 A 40,000 a 40,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
COHERUS BIOSCIENCES INC CHRS 2021-02-26 22:15:02 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 21:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 21:15:02 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 20:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 20:15:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 19:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 19:15:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 18:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 18:15:02 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 17:45:02 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 17:15:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 16:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 16:15:02 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 15:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 15:15:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 14:45:03 UTC -0.18 0.25 1800000
COHERUS BIOSCIENCES INC CHRS 2021-02-26 13:00:03 UTC -0.18 0.25 1800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund CHRS -157790.0 shares, $-2630359.3 2020-10-31 N-PORT

Elevate your investments